Topic: COVID-19

In this large-scale multi-country study, we explored intent to accept a COVID-19 vaccine and the socio-demographic and emotional determinants of uptake for 17 countries.

To identify knowledge gaps, beliefs and attitudes in relation to the COVID-19 pandemic and COVID-19 vaccine acceptance among adults in the Asia-Pacific region, the Vaccine Confidence Project conducted two waves of quantitative research in 2021 and 2022.

Little is known about how social media platforms can be used to increase COVID-19 vaccine intent. We aimed to investigate the effect of social media-based interventions on vaccine hesitancy in Japan.

A new report on the level of public confidence in vaccines among Europeans shows a strong majority believe vaccines are important, effective and safe.

Years of lies and rumours about COVID have had a contagion effect, damaging public acceptance of all vaccines, said…

Johnson & Johnson Global Public Health has created a series of unbranded research-based tools to equip vaccine confidence efforts in Africa.

Judy Salins considers herself a smart, empowered patient, but until this week, she had no idea that the medicine she takes to defend herself against Covid-19 isn’t protecting her as well as it used to.

Health authorities have warned of a new wave of Covid-19 cases and hospitalisations being…

This 2-page briefing provides an overview of the key trends and insights observed across the three waves of data collection that have been conducted as part…

This ground-breaking report analyses 734 case studies developed by health professionals.

Read the 2022 instalment of the VCPs bi-annual research report “The State of Vaccine Confidence in the EU,” which monitors public attitudes to vaccines across the continent.

In this review article, examples of hesitancy regarding the measles–mumps–rubella (MMR), human papillomavirus (HPV), and COVID-19 vaccines are used to explore the multifaceted issues that fuel vaccine hesitancy. Each of these examples is part of a larger, more complex story.